Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Equities

Walmart Partners With Scan Health Plan to Sell Medicare Advantage Coverage; Costco Also Enters Healthcare Market With Co-Branded Plans

by Team Lumida
September 16, 2026
in Equities
Reading Time: 4 mins read
A A
0
Walmart Expands Logistics Services Beyond Its Marketplace: What This Means for Investors

"Walmart" by JeepersMedia is licensed under CC BY 2.0

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp
  • Walmart Inc. and nonprofit insurer Scan Health Plan are partnering to sell co-branded Medicare Advantage plans to seniors, betting that Walmart’s data and low-price positioning can reduce overall healthcare costs. The plan will be available in two states pending regulatory clearance, with enrollment opening Oct. 15 and coverage beginning Jan. 1. Walmart plans to use its data on shopper spending habits to nudge enrollees toward healthier choices that lower claims costs.
  • Scan’s national general manager Zachary Myers said “Partnering with Walmart, in particular around its low prices, can help solve some of the challenges that our patients face around accessing the things they need to live a healthy life.” The partnership reflects a broader problem: medical care prices have risen steeply in recent years, forcing health insurers to pull back from Medicare Advantage plans and close coverage, displacing millions of beneficiaries.
  • This is Scan’s second co-branded Medicare Advantage deal with a major retailer: Costco Wholesale Corp. also announced a Scan Medicare Advantage plan in recent months. The Costco and Walmart plans will have different benefits and be offered in different states, signaling a coordinated retail expansion into the Medicare Advantage market. The moves position both retailers to capture seniors seeking lower-cost healthcare alternatives.
  • The partnerships represent significant diversification for Walmart and Costco into healthcare and insurance—markets where their data, pricing power, and customer loyalty offer competitive advantages over traditional insurers. If successful, the model could accelerate retail sector penetration into Medicare Advantage and health insurance more broadly, reshaping the competitive landscape for traditional health insurers.

What Happened?

Walmart Inc. partnered with nonprofit insurer Scan Health Plan to offer co-branded Medicare Advantage plans to seniors. The plan will be available in two states and pending regulatory clearance, with enrollment beginning Oct. 15 and coverage starting Jan. 1. Walmart plans to use its data on shopper spending and behavior to encourage healthier choices that lower overall healthcare costs. Costco Wholesale Corp. also announced a co-branded Medicare Advantage plan with Scan, with different benefits and state availability. The partnerships address a growing gap in Medicare Advantage coverage as insurers retreat amid rising medical care costs and shrinking profit margins.

Why It Matters?

For Walmart and Costco shareholders, the Medicare Advantage partnerships represent significant diversification into healthcare and insurance—markets with high recurring revenue potential and attractive demographics (aging US population). For seniors, the retail-backed plans offer potential cost savings and access to lower prices on health-related products through retailer relationships. For traditional health insurers (UnitedHealth, Anthem, Humana), retail partnerships with Scan signal new competitive threats and validate the risk that retailer data and pricing power could disintermediate traditional insurance. For Scan Health Plan, partnerships with major retailers provide capital, data, and distribution to compete in Medicare Advantage despite insurer industry headwinds. For the healthcare system, retailer entry into Medicare Advantage could accelerate cost reductions if data-driven nudges successfully improve health outcomes and lower claims.

What’s Next?

Monitor regulatory approval timeline for Walmart-Scan Medicare Advantage plan; if approved and enrollment exceeds expectations during Oct. 15-Dec. 7 period, it would validate the retail insurance model. Watch Q1 2027 earnings from Walmart and Costco for any Medicare Advantage enrollment or premium revenue guidance. Track traditional insurers’ responses (UnitedHealth, Anthem, Humana); if they announce retail partnerships or Medicare Advantage plan expansions, it would signal competitive scrambling. Monitor Scan Health Plan for announcements of additional retail partnerships; if other major retailers (Target, Amazon) join, it would signal a sector-wide shift. Also watch for regulatory pushback; if CMS or state regulators scrutinize retail Medicare Advantage plans for data privacy or anti-competitive concerns, it could slow expansion. Finally, track senior enrollment trends in Walmart/Costco plans; if adoption accelerates, it could trigger a wave of retail healthcare ventures and reshape Medicare Advantage competitive dynamics.

Affected Tickers & Coins: WMT, COST

Source: Bloomberg

Previous Post

LuxExperience’s Mytheresa Bucks Luxury Downturn With 7.6% Sales Growth, US Up 39%, as Ultra-Wealthy Spending Carries E-Commerce Platform

Next Post

‘Scaremongering About 5% Bond Yields Misses the Point’: Strong AI Investment and Economic Growth Justify Higher Treasury Rates

Recommended For You

JetBlue Shares Sink as Much as 18% to a Record Low of $2.16 a Day Before Earnings, as Creditors Line Up Restructuring Advisers

by Team Lumida
20 minutes ago

JetBlue stock fell as much as 18% to a record low of $2.16 before Tuesday’s Q3 results, after a creditor group began working with restructuring advisers.

Read more

EQT Agrees to Buy Range Resources in a $12.8 Billion All-Stock Deal, Creating the Largest US Natural Gas Producer

by Team Lumida
20 minutes ago
AI Boom Drives Massive Energy Crisis: Data Centers Demand Unprecedented Power

EQT will buy Range Resources for about $12.8 billion in stock, creating the largest US natural gas producer with about 7% of national output.

Read more

Microsoft Will Offer Buyouts to About 60,000 Workers, Roughly 27% of Its Headcount, as It Retools for the AI Era

by Team Lumida
20 minutes ago
Microsoft’s AI Ambitions: A Costly Path Forward

Microsoft will offer buyouts to about 60,000 workers at VP level and below in the US, Canada, India and the UK as it trims costs and redirects spending...

Read more

Verizon Nearly Doubles Estimates With 406,000 Postpaid Subscriber Adds, Raises Its Outlook and Signs a More Than $2 Billion AI Fiber Deal With AWS

by Team Lumida
26 minutes ago

Verizon added 406,000 monthly-bill-paying wireless subscribers, nearly double estimates, raised its forecasts and signed a $2 billion-plus AI fiber deal with AWS.

Read more

Meta Plans to Raise $95 Billion, Including $60 Billion Through an At-the-Market Program, With Nvidia, AMD and Broadcom Interested in Buying Up to $5 Billion

by Team Lumida
26 minutes ago

Meta plans to raise $95 billion in equity to fund its AI buildout, starting with $35 billion of underwritten offerings, and its shares fell 1.6%.

Read more

LKQ Ousts Its CEO and Warns Q3 Earnings Will Fall Well Short After a 9.8% Drop in European Revenue

by Team Lumida
3 days ago

LKQ expects Q3 adjusted EPS of 47 to 53 cents versus the 69 cents expected, ousted CEO Justin Jude and hired Alvarez & Marsal to review Europe.

Read more

SLB Jumps as Much as 6% as Middle East Revenue Rises 13% and It Sees Venezuela Sales More Than Doubling by Year-End

by Team Lumida
3 days ago

SLB beat estimates with 64 cents of adjusted EPS as Middle East revenue rose 13%, and its CEO sees a very compelling 2027 with Venezuela a key growth...

Read more

GM Is Headed for Its Worst Week Since January 2025, but Not One Analyst Tracked by Bloomberg Says Sell

by Team Lumida
3 days ago

GM shares fell 8% this week through Thursday, on pace for the biggest weekly drop since January 2025, yet StoneX, BNP Paribas, Evercore and RBC say buy the...

Read more

Longtime Chipotle Bull TD Cowen Moves to Hold With a Street-Low $32 Target as Fourth-Quarter Sales Soften

by Team Lumida
3 days ago

TD Cowen’s Andrew Charles, a Chipotle bull since 2019, cut the stock to hold with a Street-low $32 target, citing a soft start to the fourth quarter.

Read more

US Air Travel Is Headed for Its First Annual Decline Since 2020 as Fares Jump More Than 22%, and Airlines Say That’s Fine

by Team Lumida
3 days ago

US airport screenings are on track for their first annual decline since 2020 as fares jump more than 22%, but airlines say yield matters more than full planes.

Read more
Next Post
‘Scaremongering About 5% Bond Yields Misses the Point’: Strong AI Investment and Economic Growth Justify Higher Treasury Rates

'Scaremongering About 5% Bond Yields Misses the Point': Strong AI Investment and Economic Growth Justify Higher Treasury Rates

DOJ Backs $1.9B Bond Requirement for States Challenging Paramount-Warner Bros Merger; Trial Set for March 2027

DOJ Backs $1.9B Bond Requirement for States Challenging Paramount-Warner Bros Merger; Trial Set for March 2027

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Gold Fields Mounts ‘Charm Offensive’ to Woo Northern Star Shareholders; A$39bn Bid Rejected but Elliott Activism, Trading Discount Signal Deal Momentum May Resume

Gold Fields Mounts ‘Charm Offensive’ to Woo Northern Star Shareholders; A$39bn Bid Rejected but Elliott Activism, Trading Discount Signal Deal Momentum May Resume

October 14, 2026
Alphabet Has Lost $692 Billion in Market Value Since May — Brain Drain, Gemini Delays, and Capex Fears Are the Culprits

Alphabet Has Lost $692 Billion in Market Value Since May — Brain Drain, Gemini Delays, and Capex Fears Are the Culprits

August 27, 2026
September Rate Cut Likely as Job Market Risks Increase, Says Fed

Treasuries Hold Steady With the 10-Year at 5.12% as Oil Nears $99 and the Fed Meets in a Week

October 21, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America China Commercial Real Estate CPI data centers Donald Trump EARNINGS ELON MUSK Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC Semiconductor stock market stock surge Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018